StephenG.SwisherMD
Thoracic Surgery • Houston, TXCardiovascular Surgery
Head, Division of Surgery, Professor and Chair Department of Thoracic & Cardiovascular Surgery, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, University of Texas MD Anderson Cancer Center
Dr. Swisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Memorial Hermann - Texas Medical CenterFellowship, Thoracic Surgery, 1994 - 1996
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1986 - 1993
University of California San Diego School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - Present
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
TX State Medical License 1994 - 2026
AZ State Medical License 2022 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2022 - 2025- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB.Nathaniel Deboever, Michael Eisenberg, Jiangong Niu, William Graber, Mara B Antonoff
Journal of Surgical Oncology. 2024-12-05 - 3 citationsCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01 - Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.Nicolas Zhou, Cheuk H Leung, William N William Jr, Annikka Weissferdt, Apar Pataer
Journal for Immunotherapy of Cancer. 2024-10-23
Journal Articles
- Inhibition of thioredoxin/thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione HomeostasisJohn V Heymach, Stephen G Swisher, Jack A Roth, John D Minna, Clinical Cancer Research
- Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLCStephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research
- Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerCesar Moran, Jack A Roth, Yang Xie, John D Minna, Vassiliki A Papadimitrakopoulou, John V Heymach, Stephen G Swisher, Clinical Cancer Research
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
